14 August 2017
The US and EU are diverging on whether to continue looking into a Honeywell and DuPont automotive refrigerant production joint venture that may have constituted an anticompetitive agreement.
31 July 2017
Canada's specialist competition court has refused to dismiss the Competition Bureau's e-books case against HarperCollins, despite the company's arguments that Canadian civil antitrust law does not cover the alleged US conspiracy.
25 July 2017
Germany's Federal Cartel Office today handed down a €10.9 million fine to a German clothes maker and a major luxury clothing retailer for resale price maintenance.
17 July 2017
The EU’s competition watchdog has accused drugmaker Teva and subsidiary Cephalon – a former rival – of signing an illegal patent settlement in which Teva agreed to delay the entry of a generic sleep disorder drug.
12 July 2017
Germany’s competition enforcer has issued final guidelines on the prohibition of vertical price-fixing in the food retail sector, in a bid to broaden local companies’ understanding about the legality of communications between manufacturers and retailers.
30 June 2017
Norway’s Supreme Court has upheld an infringement decision against two taxi companies that jointly bid on a public tender, after receiving an advisory opinion from the Court of Justice of the European Free Trade Association on the legal test for a by-object restriction of competition.
28 June 2017
Australia’s competition watchdog has denied three tobacco makers’ request to act collectively with regard to retailers and wholesalers across the country that supply illicit tobacco, expressing uncertainty that the proposed action would be effective or necessary.
07 June 2017
Etienne Pfister, chief economist at France’s Competition Authority, said more empirical evidence is needed to determine whether and how the use of online pricing algorithms could potentially violate competition law, and warned regulation and oversight of such pricing programs will be costly.
07 June 2017
Lawyers defending the European Commission insist that the European Court of Justice’s Cartes Bancaires judgment does not undermine the watchdog’s decision against Servier – but the pharmaceutical company’s lawyers say the precedent should be enough to overturn the finding that Server’s agreements with generic drugmakers were by-object restrictions of competition.
06 June 2017
A lawyer for pharmaceutical company Servier said the EU’s antitrust watchdog incorrectly found that agreements delaying the entry of generic rivals to its cardiovascular drug perindopril were by-object restrictions.